Self-testing and self-management of oral anticoagulation - early assessment briefs (Alert)

Swedish Council on Technology Assessment in Health Care
Record ID 32008000082
Swedish
Authors' objectives:

Primary questions: What are the benefits of self-testing and self-management compared to using conventional management (testing and dosing at healthcare facilities) for patients needing long-term treatment with AVK drugs? What risks are associated with the different methods? The aim is also to compare the methods in terms of quality of life and cost-effectiveness.

Authors' recommendations: Self-management is at least as safe as conventional management for patients who are motivated and can manage the routines on their own (Evidence Grade 1)*. The benefits of self-management for these patients mainly involve improvements in quality of life, eg, greater independence from health services. There is insufficient* scientific evidence to assess self-management in relation to conventional management over the longer term. There is insufficient* scientific evidence to compare self-testing alone with conventional management. There is insufficient* scientific evidence to assess the respective cost-effectiveness of self-testing and self-management.
Authors' methods: Review
Details
Project Status: Completed
URL for project: http://www.sbu.se/Published
Year Published: 2007
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Sweden
MeSH Terms
  • Administration, Oral
  • Drug Monitoring
  • International Normalized Ratio
  • Self Administration
  • Self Care
  • Treatment Outcome
  • Anticoagulants
Contact
Organisation Name: Swedish Agency for Health Technology Assessment and Assessment of Social Services
Contact Address: P.O. Box 3657, SE-103 59 Stockholm, Sweden. Tel: +46 8 4123200, Fax: +46 8 4113260
Contact Name: registrator@sbu.se
Contact Email: registrator@sbu.se
Copyright: Swedish Council on Technology Assessment in Health Care (SBU)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.